Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 24,706 | 2,843 | 3,100 | 9,283 | 2,922 |
| Operating Income | -24,706 | -2,843 | -3,100 | -9,283 | -2,922 |
| Interest Expense | 271 | 186 | 18 | 50 | 211 |
| Other Income | 31 | -79 | -2,049 | -557 | 6 |
| Pre-tax Income | -24,946 | -3,108 | -5,168 | -9,890 | -3,127 |
| Income Tax | 0 | 4 | N/A | 2 | N/A |
| Net Income Continuous | -24,946 | -3,112 | -5,168 | -9,892 | -3,127 |
| Net Income | $-24,946 | $-3,112 | $-5,168 | $-9,892 | $-3,127 |
| EPS Basic Total Ops | -3.17 | -0.80 | -1.37 | -2.19 | -1.58 |
| EPS Basic Continuous Ops | -3.17 | -0.80 | -1.37 | -3.94 | -1.58 |
| EPS Diluted Total Ops | -3.17 | -0.80 | -1.37 | -2.19 | -1.58 |
| EPS Diluted Continuous Ops | -3.17 | -0.80 | -1.37 | -3.94 | -1.58 |
| EBITDA(a) | $-24,575 | $-2,809 | $-3,067 | $-9,242 | $-2,728 |